Chemoinformaics analysis of Sexangularetin 3-glucoside
| Molecular Weight | 478.406 | nRot | 5 |
| Heavy Atom Molecular Weight | 456.23 | nRig | 24 |
| Exact Molecular Weight | 478.111 | nRing | 4 |
| Solubility: LogS | -4.017 | nHRing | 2 |
| Solubility: LogP | -0.04 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 61.0334 |
| nHD | 7 | BPOL | 29.8826 |
| QED | 0.254 |
| Synth | 4.026 |
| Natural Product Likeliness | 2.153 |
| NR-PPAR-gamma | 0.869 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.834 |
| HIA | 0.622 |
| CACO-2 | -6.181 |
| MDCK | 0.0000191 |
| BBB | 0.047 |
| PPB | 0.832744 |
| VDSS | 0.946 |
| FU | 0.150831 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.07 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.404 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.171 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.02 |
| CL | 4.772 |
| T12 | 0.793 |
| hERG | 0.014 |
| Ames | 0.82 |
| ROA | 0.117 |
| SkinSen | 0.06 |
| Carcinogencity | 0.097 |
| EI | 0.016 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.917 |
| Antiviral | Yes |
| Prediction | 0.932103 |